TABLE OF CONTENTS
Volume 63, Issue S84 (May 2003)
Uremic Toxicity |
Oxidative Stress and No |
Endothelial Dysfunction |
Inflammation, Cytokines, and the Immune System |
Metabolism and Inflammation |
Metabolism And Inflammation |
Dyslipidemias |
Homocysteine |
Carboxyl Stress And Ages |
Uremia, Genes, and the Heart |
Epidemiology And Clinical Trials |
Epidemiology and Clinical Trials
Introduction
Introduction FREE
Thomas Quaschning and Christoph Wanner Guest Editors
Kidney Int 63: S1-S1; doi:10.1046/j.1523-1755.63.s84.51.x
Uremic Toxicity
The uremic syndrome: Therapeutic-evaluative discordance FREE
Salim Mujais and Lee Henderson
Kidney Int 63: S2-S5; doi:10.1046/j.1523-1755.63.s84.29.x
New insights in uremic toxins FREE
Raymond Vanholder, Griet Glorieux, Rita De Smet and Norbert Lameire for the European Uremic Toxin Work Group (EUTox)
Kidney Int 63: S6-S10; doi:10.1046/j.1523-1755.63.s84.43.x
Are advanced oxidation protein products potential uremic toxins? FREE
Véronique Witko-Sarsat, Valérie Gausson and Béatrice Descamps-Latscha
Kidney Int 63: S11-S14; doi:10.1046/j.1523-1755.63.s84.47.x
Immunoglobulin light chains in uremia FREE
Gerald Cohen
Kidney Int 63: S15-S18; doi:10.1046/j.1523-1755.63.s84.8.x
N-methyl-2-pyridone-5-carboxamide: A novel uremic toxin? FREE
Boleslaw Rutkowski, Ewa Slominska, Marek Szolkiewicz, Ryszard T Smolenski, Cindy Striley, Przemyslaw Rutkowski and Julian Swierczynski
Kidney Int 63: S19-S21; doi:10.1046/j.1523-1755.63.s84.36.x
Oxidative Stress and No
Nitric oxide, oxidative stress, and apoptosis FREE
Bernhard Brüne, Jie Zhou and Andreas von Knethen
Kidney Int 63: S22-S24; doi:10.1046/j.1523-1755.63.s84.6.x
Nitric oxide in uremia: Effects of several potentially toxic guanidino compounds FREE
P P De Deyn, R Vanholder and R D'Hooge
Kidney Int 63: S25-S28; doi:10.1046/j.1523-1755.63.s84.9.x
Oxidative consumption of nitric oxide: A potential mediator of uremic vascular disease FREE
R C Thuraisingham and M M Yaqoob
Kidney Int 63: S29-S32; doi:10.1046/j.1523-1755.63.s84.41.x
5-Lipoxygenase-mediated mitochondrial damage and apoptosis of mononuclear cells in ESRD patients FREE
Mauro Maccarrone, Massimo Taccone-Gallucci and Alessandro Finazzi-Agrò
Kidney Int 63: S33-S36; doi:10.1046/j.1523-1755.63.s84.26.x
Asymmetric dimethylarginine: A cardiovascular risk factor in renal disease? FREE
Danilo Fliser, Jan T Kielstein, Hermann Haller and Stefanie M Bode-Böger
Kidney Int 63: S37-S40; doi:10.1046/j.1523-1755.63.s84.11.x
Endothelial Dysfunction
Endothelial permeability in uremia FREE
Steven J Harper and David O Bates
Kidney Int 63: S41-S44; doi:10.1046/j.1523-1755.63.s84.15.x
Endothelial dysfunction and inflammation: What is the link? FREE
Jan Galle, Thomas Quaschning, Stefan Seibold and Christoph Wanner
Kidney Int 63: S45-S49; doi:10.1046/j.1523-1755.63.s84.12.x
Endothelium-dependent vasodilation and oxidative stress in chronic renal failure: Impact on cardiovascular disease FREE
Margus Annuk, Mihkel Zilmer and Bengt Fellström
Kidney Int 63: S50-S53; doi:10.1046/j.1523-1755.63.s84.2.x
Vasopeptidase inhibition: A new treatment approach for endothelial dysfunction FREE
Thomas Quaschning, Jan Galle and Christoph Wanner
Kidney Int 63: S54-S57; doi:10.1046/j.1523-1755.63.s84.35.x
Inflammation, Cytokines, and the Immune System
Update on C-reactive protein as a risk marker in cardiovascular disease FREE
Wolfgang Koenig
Kidney Int 63: S58-S61; doi:10.1046/j.1523-1755.63.s84.22.x
Relationship between advanced glycoxidation end products, inflammatory markers/acute-phase reactants, and some autoantibodies in chronic hemodialysis patients FREE
Marta Kalousová, Tomá
Zima, Vladimír Tesa
, Sylvie Sulková and Lenka Fialová
Kidney Int 63: S62-S64; doi:10.1046/j.1523-1755.63.s84.19.x
Adipose tissue as a source of inflammatory cytokines in health and disease: Focus on end-stage renal disease FREE
Carmine Zoccali, Francesca Mallamaci and Giovanni Tripepi
Kidney Int 63: S65-S68; doi:10.1046/j.1523-1755.63.s84.50.x
Do circulating cytokines really matter in sepsis? FREE
Ciro Tetta, Rinaldo Bellomo, Vincent D'Intini, Concetta De Nitti, Paola Inguaggiato, Alessandra Brendolan and Claudio Ronco
Kidney Int 63: S69-S71; doi:10.1046/j.1523-1755.63.s84.40.x
The effect of viable Chlamydia pneumoniae on serum cytokines and adhesion molecules in hemodialysis patients FREE
George Tsirpanlis, Stylianos Chatzipanagiotou, Anastasios Ioannidis, Kostantina Ifanti, Pantelis Bagos, Antonis Lagouranis, Cornelia Poulopoulou and Chrysoula Nicolaou
Kidney Int 63: S72-S75; doi:10.1046/j.1523-1755.63.s84.42.x
Uremia-associated immune defect: The IL-10–CRP axis FREE
Matthias Girndt, Christof Ulrich, Harald Kaul, Urban Sester, Martina Sester and Hans Köhler
Kidney Int 63: S76-S79; doi:10.1046/j.1523-1755.63.s84.14.x
Metabolism and Inflammation
Morphology of the heart and arteries in renal failure FREE
Karin Tyralla and Kerstin Amann
Kidney Int 63: S80-S83; doi:10.1046/j.1523-1755.63.s84.1.x
Deficiencies of calcium-regulatory proteins in dialysis patients: A novel concept of cardiovascular calcification in uremia FREE
Markus Ketteler, Christoph Wanner, Thomas Metzger, Philipp Bongartz, Ralf Westenfeld, Ulrich Gladziwa, Leon J Schurgers, Cees Vermeer, Willi Jahnen-Dechent and Jürgen Floege
Kidney Int 63: S84-S87; doi:10.1046/j.1523-1755.63.s84.21.x
Inflammation, arteriosclerosis, and cardiovascular therapy in hemodialysis patients FREE
Gérard M London, Sylvain J Marchais, Alain P Guerin, Fabien Metivier, Hassan Adda and Bruno Pannier
Kidney Int 63: S88-S93; doi:10.1046/j.1523-1755.63.s84.25.x
Factors that affect albumin concentration in dialysis patients and their relationship to vascular disease FREE
George A Kaysen and Burl R Don
Kidney Int 63: S94-S97; doi:10.1046/j.1523-1755.63.s84.20.x
Metabolism And Inflammation
Adiponectin is markedly increased in patients with nephrotic syndrome and is related to metabolic risk factors FREE
Carmine Zoccali, Francesca Mallamaci, Vincenzo Panuccio, Giovanni Tripepi, Sebastiano Cutrupi, Saverio Parlongo, Francesco Catalano, Sachiyo Tanaka, Noriyuki Ouchi, Shinji Kihara, Tohru Funahashi and Yuji Matsuzawa
Kidney Int 63: S98-S102; doi:10.1046/j.1523-1755.63.s84.49.x
Protein uptake disturbs collagen homeostasis in proximal tubule-derived cells FREE
Verena Wohlfarth, Karina Drumm, Sigrid Mildenberger, Ruth Freudinger and Michael Gekle
Kidney Int 63: S103-S109; doi:10.1046/j.1523-1755.63.s84.13.x
Dyslipidemias
Dialysis modalities and dyslipidemia FREE
Per-Ola Attman, Ola Samuelsson, Ann-Cathrine Johansson, James B Moberly and Petar Alaupovic
Kidney Int 63: S110-S112; doi:10.1046/j.1523-1755.63.s84.3.x
Prevalence of dyslipidemic risk factors in hemodialysis and CAPD patients FREE
Florian Kronenberg, Arno Lingenhel, Ulrich Neyer, Karl Lhotta, Paul König, Martin Auinger, Martin Wiesholzer, Helene Andersson and Hans Dieplinger
Kidney Int 63: S113-S116; doi:10.1046/j.1523-1755.63.s84.23.x
Non–high-density lipoprotein cholesterol (non-HDL-C) as a predictor of cardiovascular mortality in patients with end-stage renal disease FREE
Yoshiki Nishizawa, Tetsuo Shoji, Ryusuke Kakiya, Yoshihiro Tsujimoto, Tsutomu Tabata, Eiji Ishimura, Tatsuya Nakatani, Takami Miki and Masaaki Inaba
Kidney Int 63: S117-S120; doi:10.1046/j.1523-1755.63.s84.30.x
Hypertriglyceridemia in patients with chronic renal failure: Possible mechanisms FREE
Berthil H C M T Prinsen, Monique G M de Sain-van der Velden, Eelco J P de Koning, Hein A Koomans, Ruud Berger and Ton J Rabelink
Kidney Int 63: S121-S124; doi:10.1046/j.1523-1755.63.s84.34.x
New insights into the effects of the protein moiety of oxidized LDL (oxLDL) FREE
Stéphanie Vicca, Ziad A Massy, Carole Hennequin, Djamel Rihane, Thao Nguyen-Khoa, Tilman B Drüeke and Bernard Lacour
Kidney Int 63: S125-S127; doi:10.1046/j.1523-1755.63.s84.44.x
The association of antibodies against oxidized low-density lipoprotein with atherosclerosis in hemodialysis patients FREE
Tetsuo Shoji, Eiji Kimoto, Kayo Shinohara, Masanori Emoto, Eiji Ishimura, Takami Miki, Yoshihiro Tsujimoto, Tsutomu Tabata and Yoshiki Nishizawa
Kidney Int 63: S128-S130; doi:10.1046/j.1523-1755.63.s84.37.x
Homocysteine
Homocysteine, renal function, and risk of cardiovascular disease FREE
Robert Clarke, Sarah Lewington and Martin Landray
Kidney Int 63: S131-S133; doi:10.1046/j.1523-1755.63.s84.7.x
Potential strategies to normalize the levels of homocysteine in chronic renal failure patients FREE
Ziad A Massy
Kidney Int 63: S134-S136; doi:10.1046/j.1523-1755.63.s84.28.x
Possible mechanisms of homocysteine toxicity FREE
Alessandra F Perna, Diego Ingrosso, Cinzia Lombardi, Filomena Acanfora, Ersilia Satta, Concetta Maria Cesare, Eleonora Violetti, Maria Maddalena Romano and Natale G De Santo
Kidney Int 63: S137-S140; doi:10.1046/j.1523-1755.63.s84.33.x
Genetic determinants of the homocysteine level FREE
Gere Sunder-Plassmann and Manuela Födinger
Kidney Int 63: S141-S144; doi:10.1046/j.1523-1755.63.s84.52.x
Carboxyl Stress And Ages
AGEs in foods: Do they play a role in uremia? FREE
Thomas Henle
Kidney Int 63: S145-S147; doi:10.1046/j.1523-1755.63.s84.16.x
Glucose degradation products in peritoneal dialysis fluids: Do they harm? FREE
Janusz Witowski, Achim Jörres, Katarzyna Korybalska, Krzysztof Ksiazek, Justyna Wisniewska-Elnur, Thorsten O Bender, Jutta Passlick-Deetjen and Andrzej Breborowicz
Kidney Int 63: S148-S151; doi:10.1046/j.1523-1755.63.s84.18.x
Immunohistochemical detection of an AGE, a ligand for macrophage receptor, in peritoneum of CAPD patients FREE
Sakurako Nakamura, Kazuki Tobita, Tetsuya Tachikawa, Suguru Akamatsu, Yoshifumi Ohno, Ayumi Kan, Misaki Katsuragawa, Koichi Yasumura, Shigeru Miyazaki, Shinji Sakai, Takashi Morita, Yoshihei Hirashawa and Toshimitsu Niwa
Kidney Int 63: S152-S157; doi:10.1046/j.1523-1755.63.s84.31.x
Peritoneal dialysis: Changes to the structure of the peritoneal membrane and potential for biocompatible solutions FREE
John D Williams, Kathrine J Craig, Nicholas Topley and Geraint T Williams
Kidney Int 63: S158-S161; doi:10.1046/j.1523-1755.63.s84.46.x
Uremia, Genes, and the Heart
Genetic approaches in the clinical investigation of complex disorders: Malnutrition, inflammation, and atherosclerosis (MIA) as a prototype FREE
Roberto Pecoits-Filho, Louise Nordfors, Bengt Lindholm, Catherine M Hoff, Martin Schalling and Peter Stenvinkel
Kidney Int 63: S162-S167; doi:10.1046/j.1523-1755.63.s84.39.x
Cardiovascular pharmacogenetics: On the way toward individually tailored drug therapy FREE
Winfried Siffert
Kidney Int 63: S168-S171; doi:10.1046/j.1523-1755.63.s84.38.x
A functional variant of the myeloperoxidase gene is associated with cardiovascular disease in end-stage renal disease patients FREE
Roberto Pecoits-Filho, Peter Stenvinkel, Alicia Marchlewska, Olof Heimburger, Peter Bárány, Catherine M Hoff, Clifford J Holmes, Mohamed Suliman, Bengt Lindholm, Martin Schalling and Louise Nordfors
Kidney Int 63: S172-S176; doi:10.1046/j.1523-1755.63.s84.32.x
Calpain is a mediator of myocardial injury in experimental uremia: Is it activated by endogenous ouabain? FREE
Steven M Harwood, David A Allen, Martin J Raftery and Muhammad M Yaqoob
Kidney Int 63: S177-S180; doi:10.1046/j.1523-1755.63.s84.48.x
Fabry disease: Diagnosis and treatment FREE
Frank Breunig, Frank Weidemann, Meinrad Beer, Andreas Eggert, Vera Krane, Matthias Spindler, Jörn Sandstede, Jörg Strotmann and Christoph Wanner
Kidney Int 63: S181-S185; doi:10.1046/j.1523-1755.63.s84.5.x
Genetic aspects of diabetic nephropathy FREE
Tom H Lindner, Detlev Mönks, Christoph Wanner and Mario Berger
Kidney Int 63: S186-S191; doi:10.1046/j.1523-1755.63.s84.24.x
Epidemiology And Clinical Trials
Cardiovascular risk in patients with mild renal insufficiency FREE
Johannes F E Mann, Hertzel C Gerstein, Ioana Dulau-Florea and Eva Lonn
Kidney Int 63: S192-S196; doi:10.1046/j.1523-1755.63.s84.27.x
Cardiac arrest in dialysis patients: Approaches to alter an abysmal outcome FREE
Charles A Herzog
Kidney Int 63: S197-S200; doi:10.1046/j.1523-1755.63.s84.17.x
Epidemiology and Clinical Trials
Cardiovascular risk factors in predialysis patients: Baseline data from the Chronic Renal Impairment in Birmingham (CRIB) study FREE
David C Wheeler, John N Townend and Martin J Landray
Kidney Int 63: S201-S203; doi:10.1046/j.1523-1755.63.s84.45.x
Why do we need a statin trial in hemodialysis patients? FREE
Bengt C Fellström, Hallvard Holdaas and Alan G Jardine
Kidney Int 63: S204-S206; doi:10.1046/j.1523-1755.63.s84.10.x
